Two of the projects our team are working for our pharma clients have been published !
With those 2 articles, Soladis records its 95th and 96th publications.
« Basophils from allergic patients are neither hyper-responsive to activation signals nor hypo-responsive to inhibition signals. », a study published in the Journal of Allergy and Clinical Immunology.
« Five-Year Antibody Persistence Following a Japanese Encephalitis Chimeric Virus Vaccine (JE-CV) Booster in JE-CV-Primed Children in the Philippines. », published in The Journal of Infectious Diseases.
Soladis - France (siège)
6-8 rue Bellecombe
69006 LYON - FRANCE
Soladis GmbH - Suisse
Lange Gasse 15
Soladis Inc. - USA
185 Alewife Brook Pkwy, Unit 210
Cambridge, MA 02138-1100
545 King Street West, Suite 309,
TORONTO, ON M5V 1M1